GlassScriptPhysician profile
Dakota K Degroot
NPI 1790561546
$931.92
in general payments reported to CMS, 2019-2025
12 companies · $511 in 2025
The $511 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $17.18 · 2024: $403 · 2025: $511.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Education: $54.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.97 |
| Education | $54.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $355.22 | 2024-2025 | |
| Inspire Medical Systems, INC. | $208.50 | 2024-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $96.89 | 2024-2025 | Dupixent |
| Sanofi-Aventis U.S. LLC | $54.95 | 2025 | |
| Integra Lifesciences Corporation | $41.44 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Glaxosmithkline, LLC. | $35.39 | 2024-2025 | Nucala |
| Phadia US INC. | $32.61 | 2023-2024 | Immunocap |
| Smith+Nephew, INC. | $28.45 | 2024 | Tula |
| Alk-Abello, INC | $24.27 | 2024 | Standardized Mite D. Farinae, Pre-Pen, Timothy, Standardized |
| Genentech USA, INC. | $21.77 | 2024 | Xolair |
| Stryker Corporation | $17.24 | 2024 | Medline Industries, INC. |
| Hikma Pharmaceuticals USA | $15.19 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dakota Degroot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.